Pulmonology Department, Hospital Germans Trias i Pujol, Badalona, Spain.
Clin Exp Metastasis. 2013 Apr;30(4):521-8. doi: 10.1007/s10585-012-9556-3. Epub 2012 Nov 30.
Intrathoracic lymph node enlargement is a common finding in patients with extrathoracic malignancies. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a technique that is commonly used for lung cancer diagnosis and staging but that has not been widely investigated for the diagnosis of enlarged mediastinal and lobar lymph nodes in patients with extrathoracic malignancies. We conducted a retrospective study of 117 patients with extrathoracic malignancies who underwent EBUS-TBNA for diagnosis of intrathoracic lymph node enlargement from October 2005 to December 2009 and compared the EBUS-TBNA findings with the final diagnoses. EBUS-TBNA diagnosed mediastinal metastases in 51 of the 117 (43.6 %) cases and gave an alternate diagnosis or ruled out the presence of malignancy in 35 (56.4 %). Fourteen of these 35 patients underwent further surgical investigation, while the remaining 21 had clinical and radiological follow-up for 18 months. No false negatives were found in the surgery group. In the follow-up group, 13 patients had stable or regressive lymphadenopathy, and eight developed clinicoradiological progression and were assumed to have been false negatives by EBUS-TBNA. The sensitivity and negative predictive value of EBUS-TBNA were 86.4 and 75 %, respectively. Immunohistochemical staining (IHC) was performed in 80.4 % of the samples obtained by EBUS-TBNA. In samples obtained from ten patients with metastatic breast cancer, estrogen receptor expression was successfully assessed in eight patients and progesterone receptor and human epidermal growth factor receptor 2 in four. EBUS-TBNA is an accurate procedure for the diagnosis of thoracic lymph node metastases in patients with extrathoracic malignancies and should be an initial diagnostic tool in these patients. Furthermore, EBUS-TBNA can obtain high-quality specimens from metastatic lymph nodes for use in molecular analyses.
胸内淋巴结肿大是胸外恶性肿瘤患者的常见表现。经支气管超声引导针吸活检术(EBUS-TBNA)是一种常用于肺癌诊断和分期的技术,但尚未广泛用于诊断胸外恶性肿瘤患者纵隔和肺叶淋巴结肿大。我们对 2005 年 10 月至 2009 年 12 月期间 117 例因胸内淋巴结肿大接受 EBUS-TBNA 诊断的胸外恶性肿瘤患者进行了回顾性研究,并将 EBUS-TBNA 结果与最终诊断进行了比较。EBUS-TBNA 在 117 例患者中的 51 例(43.6%)中诊断为纵隔转移,并在 35 例(56.4%)中给出了替代诊断或排除了恶性肿瘤的存在。这 35 例患者中有 14 例进一步接受了外科检查,而其余 21 例接受了 18 个月的临床和放射学随访。手术组未发现假阴性病例。在随访组中,13 例患者的淋巴结病稳定或消退,8 例患者出现临床和影像学进展,被认为是 EBUS-TBNA 的假阴性病例。EBUS-TBNA 的敏感性和阴性预测值分别为 86.4%和 75%。EBUS-TBNA 获得的标本中有 80.4%进行了免疫组织化学染色(IHC)。在 10 例转移性乳腺癌患者的标本中,成功评估了 8 例患者的雌激素受体表达,4 例患者的孕激素受体和人表皮生长因子受体 2 表达。EBUS-TBNA 是一种准确的诊断胸外恶性肿瘤患者胸内淋巴结转移的方法,应作为这些患者的初始诊断工具。此外,EBUS-TBNA 可以从转移性淋巴结获得高质量的标本,用于分子分析。